Back to Stifel Financial Corp. Stifel Financial Corp.

ARWR

21 quarters

Position history for Stifel Financial Corp.Stifel Financial Corp.'s holdings in Arrowhead Pharmaceuticals, Inc.

Yes. Stifel holds 73,294 shares of ARWR (Arrowhead Pharmaceuticals), worth $6M, as of its Q2 2026 13F filing. It increased the position from 11,696 shares in Q1 2026. Stifel has held ARWR since Q4 2025, across 3 quarterly 13F filings.

Current Value

$6M

Current Shares

73,294

Total Value Change

+$5.7M

Total Shares Change

+48,598

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
73,294
+526.7%
$6M0.0%$81.51
44
2026-Q1
Decreased
11,696
-1.0%
$733,3510.0%$62.70
0
2025-Q4
New
11,811
-
$784,1300.0%$66.39
34
2023-Q1
Exited
0
-100.0%
$00.0%$25.40
0
2022-Q4
Decreased
19,821
-6.8%
$803,9490.0%$40.56
0
2022-Q3
Decreased
21,273
-1.4%
$703,0000.0%$33.05
0
2022-Q2
Decreased
21,579
-1.5%
$760,0000.0%$35.21
0
2022-Q1
Decreased
21,917
-3.5%
$1M0.0%$45.99
0
2021-Q4
Decreased
22,708
-0.6%
$1.5M0.0%$66.30
0
2021-Q3
Decreased
22,853
-0.4%
$1.4M0.0%$62.43
0
2021-Q2
Increased
22,936
+1.7%
$1.9M0.0%$82.82
26
2021-Q1
Increased
22,560
+0.8%
$1.5M0.0%$66.31
26
2020-Q4
Decreased
22,383
-0.4%
$1.7M0.0%$76.73
0
2020-Q3
Increased
22,466
+3.5%
$967,0000.0%$43.06
26
2020-Q2
Decreased
21,701
-7.3%
$937,0000.0%$43.19
0
2020-Q1
Decreased
23,413
-2.3%
$675,0000.0%$28.77
0
2019-Q4
Decreased
23,975
-0.4%
$1.5M0.0%$63.43
0
2019-Q3
Decreased
24,068
-0.1%
$678,0000.0%$28.18
0
2019-Q2
Decreased
24,090
-1.5%
$641,0000.0%$26.50
0
2019-Q1
Decreased
24,468
-0.9%
$450,0000.0%$18.35
0
2018-Q4
First report
24,696
-
$306,0000.0%$12.42
0

Other major holders of ARWR: BlackRock, Inc., Vanguard Group Inc., Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used